Jalalon, Ashmira Chlea E.

HRN: 27-27-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/06/2026
03/13/2026
IV DRIP
350mg
Q6
PCAP-C
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: